VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: BYR-59044 |   Pharmaceuticals and Healthcare

Historical data: 2017 - 2023

Forecast period: 2025 - 2031

Quantitative units: Revenue in USD million and CAGR from 2025 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Vaccine for Porcine Reproductive and Respiratory Syndrome (PRRS) Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET

7.1 GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE (2017 - 2031) (USD MILLION)

8.1 GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

8.2 GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

9.1 GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

9.2 GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

10.1 GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY REGION (2017 - 2023) (USD MILLION)

10.2 GLOBAL VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY REGION (2025 - 2031) (USD MILLION)

11.1 NORTH AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

11.2 NORTH AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

11.3 NORTH AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

11.4 NORTH AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

11.5 NORTH AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

11.6 NORTH AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

12.1 EUROPE VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

12.2 EUROPE VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

12.3 EUROPE VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

12.4 EUROPE VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

12.5 EUROPE VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

12.6 EUROPE VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

13.1 ASIA PACIFIC VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

13.2 ASIA PACIFIC VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

13.3 ASIA PACIFIC VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

13.4 ASIA PACIFIC VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

13.5 ASIA PACIFIC VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

13.6 ASIA PACIFIC VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

14.1 LATIN AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)/p>

14.2 LATIN AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

14.3 LATIN AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

14.4 LATIN AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

14.5 LATIN AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

14.6 LATIN AMERICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2017 - 2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY COUNTRY (2025 - 2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2017 - 2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY TYPE (2025 - 2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2017 - 2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA VACCINE FOR PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) MARKET SIZE AND SHARE BY APPLICATION (2025 - 2031)< (USD MILLION)/p>

16.1 CNADC

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 Boehringer-Ingelheim

16.3 MSD Animal Health

16.4 Sinopharm

16.5 Ceva

16.6 Chengdu Tianbang Biological Products Co. Ltd.

16.7 Tianjin Ruipu Biological Technology Co. Ltd.

16.8 Qilu Animal Health

16.9 Guangdong Wens Dahuanong Biotechnology Co. Ltd.

16.10 CAVAC

16.11 Komipharm

16.12 Agrovet

16.13 Bioveta

16.14 Jinyu Bio-Technology

16.15 Phibro Animal Health

16.16 Tiankang

16.17 Zoetis

16.18 Guangdong Yongshun Biological Pharmaceutical Co Ltd

16.19 Plec Bioengineering Co. Ltd.

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

By Type

Live Vaccine
Inactivated Vaccine

By Application

Government Tender
Marketing

Companies

CNADC
Boehringer-Ingelheim
MSD Animal Health
Sinopharm
Ceva
Chengdu Tianbang Biological Products Co. Ltd.
Tianjin Ruipu Biological Technology Co. Ltd.
Qilu Animal Health
Guangdong Wens Dahuanong Biotechnology Co. Ltd.
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Phibro Animal Health
Tiankang
Zoetis
Guangdong Yongshun Biological Pharmaceutical Co Ltd
Plec Bioengineering Co. Ltd.

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.